Skip to content
value.today

Eli Lilly and Company vs Johnson & Johnson

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Eli Lilly and Company is the larger company by market value: $1.20 T against $652.5 B for Johnson & Johnson, 1.8 times as much (market caps of Oct 26, 2026 for Eli Lilly and Company and Oct 29, 2026 for Johnson & Johnson).
  • Johnson & Johnson had more revenue: $94.2 B against $65.2 B for Eli Lilly and Company, both in the year to December 2025.
  • Johnson & Johnson earned more: net income of $26.8 B against $20.6 B for Eli Lilly and Company.
  • Eli Lilly and Company keeps more of each dollar of sales: a net margin of 31.7% against 28.5% for Johnson & Johnson.
  • Johnson & Johnson employs more people: 138,200 against 50,000 at Eli Lilly and Company. Each employee brings in about $1,303,580 of revenue at Eli Lilly and Company and $681,570 at Johnson & Johnson.
  • On price to earnings, Eli Lilly and Company trades at 43.4× and Johnson & Johnson at 40.5×: investors pay more for each dollar of Eli Lilly and Company's profit.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

02344677019352020202120222023202420252026Eli Lilly and Company 935Johnson & Johnson 170

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$24B$47B$71B$94B201720182019202020212022202320242025Eli Lilly and Company $65BJohnson & Johnson $94B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureEli Lilly and Company
LLY · #13 in the world
Johnson & Johnson
JNJ · #23 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded18761886
Size
Market cap$1.20 T$652.5 B
Revenue$65.2 B$94.2 B
Net income$20.6 B$26.8 B▲ best
Employees50,000138,200
Valuation
P/E ratio43.4×40.5×
Price to sales13.9×6.6×
Price to book45.1×8.0×
Free cash flow yield—3.0%
Profitability
Gross margin83.0%—
Net margin31.7%—
Return on equity101.2%—
Growth
Revenue growth44.7%—
Revenue growth, 3 years a year31.7%—
Earnings per share growth96.0%—
Financial strength
Debt to equity1.5×—
Shareholder returns
Dividend yield0.5%—
Shareholder yield0.8%—
Strength scores
Piotroski F-score7 of 9—
Altman Z-score zone——
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Oct 2026

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Eli Lilly and Company or Johnson & Johnson?

Eli Lilly and Company is the larger company by market value: $1.20 T against $652.5 B for Johnson & Johnson, 1.8 times as much (market caps of Oct 26, 2026 for Eli Lilly and Company and Oct 29, 2026 for Johnson & Johnson).

Which makes more money, Eli Lilly and Company or Johnson & Johnson?

Johnson & Johnson had more revenue: $94.2 B against $65.2 B for Eli Lilly and Company, both in the year to December 2025. Johnson & Johnson earned more: net income of $26.8 B against $20.6 B for Eli Lilly and Company.

Which is more profitable, Eli Lilly and Company or Johnson & Johnson?

Eli Lilly and Company keeps more of each dollar of sales: a net margin of 31.7% against 28.5% for Johnson & Johnson.

Which has more employees, Eli Lilly and Company or Johnson & Johnson?

Johnson & Johnson employs more people: 138,200 against 50,000 at Eli Lilly and Company. Each employee brings in about $1,303,580 of revenue at Eli Lilly and Company and $681,570 at Johnson & Johnson.

Is Eli Lilly and Company cheaper than Johnson & Johnson?

On price to earnings, Eli Lilly and Company trades at 43.4× and Johnson & Johnson at 40.5×: investors pay more for each dollar of Eli Lilly and Company's profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.

Sources#

Every figure on this page comes from these, with the date shown next to it.